Andere talen Seegene, Inc.

Aandelen

A096530

KR7096530001

Biotechnologie & Medisch Onderzoek

Slotkoers Korea S.E. Andere beurzen 24-01-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
24.100,00 ^KRW	-1,23%		-2,43%	+5,70%

14/11	Seegene, Inc. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2024	CI
08/10	Seegene, Inc. en Werfen, S.A. sluiten partnerschapsovereenkomst af over een initiatief voor het delen van technologie	CI

Andere talen

Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	14/11
/C O R R E C T I O N -- Seegene Inc./	28-10-24
Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative	24-10-24
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative	08-10-24
Seegene, Inc. and Werfen, S.A. Finalize Partnership Agreement on Technology-Sharing Initiative	08-10-24
Seegene, Inc.(KOSDAQ:A096530) dropped from FTSE All-World Index	23-09-24
Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1	09-09-24
Seegene and Springer Nature Launch Nature Awards MDx Impact Grants, to Innovate Syndromic PCR Diagnostic Assays	03-09-24
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays	02-09-24
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration	26-08-24
Seegene, Inc. Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration	26-08-24
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	14-08-24
Seegene Showcased its Multiplex Technology at ADLM 2024	05-08-24
Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024	16-07-24
Seegene, Inc.'s Equity Buyback Plan Extended till July 14, 2025.	12-07-24
Seegene and Springer Nature Announce Strategic Alliance	16-05-24
Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16-05-24
Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'	09-04-24
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"	08-04-24
Seegene and Springer Nature Announce Awardees for the Open Innovation Program	15-03-24
Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14-03-24
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'	24-01-24
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases	24-01-24
Seegene obtains ISO45001 certification	27-12-23
Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy; Expanded Collaboration Aims To Improve Syndromic Infectious Disease Testing	14-12-23

Word de lid om toegang te krijgen tot meer nieuws.

Gratis inschrijven

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Seegene, Inc.

Aandelen

A096530

KR7096530001

Biotechnologie & Medisch Onderzoek

Andere talen

Filters